IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
HPC Biosciences IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 15.75 Cr. The company is based in New Delhi and caters to Agro sector. Guiness Corporate Advisors is the merchant banker of HPC Biosciences IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 17th January 2013.
HPC Biosciences IPO open date is 1st March 2013 and close date is 5th March 2013. IPO Allotment Date is 30th November -0001 and Listing date is 19th March 2013.
IPO
Size:
₹ 15.75 Cr.
Avg IPO Size (Sector Based)
: ₹
19.40 cr.
Sector: Agro
SME
IPO so far:
79
Merchant Banker:
Guiness Corporate
SME
IPO by BRLM so far:
47
City:
New Delhi
SME
IPO so far:
165
Revenue (annualised):
₹
8.74
cr. 
PE
Ratio:
8.00x
Average Sector PE Ratio: 18.21x
HPC Biosciences IPO size is ₹ 15.75 Cr. with IPO price of ₹ 35.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Guiness Corporate Advisors Private Limited is the book-running lead manager of the HPC Biosciences IPO. Cameo Corporate Services Limited is the Registrar and Market Maker is Narayan Securitirs Limited for HPC Biosciences IPO.
HPC Biosciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
HPC Biosciences IPO, based in New Delhi, operates in the Agro sector with a focus on agriculture operations of cultivation processing and distribution of agriculture. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. HPC Biosciences IPO size is ₹ 15.75 Cr. with fresh issue size of ₹ 16 and Offer for sale being ₹ Nil
The IPO allotment date for HPC Biosciences IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check HPC Biosciences IPO allotment status on the registrars website, Cameo Corporate Services Limited . HPC Biosciences IPO refund dates are 30th November -0001.
HPC Biosciences IPO is expected to be listed on 19th March 2013.
The upper price band for the HPC Biosciences IPO is set at ₹ 35.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on HPC Biosciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the HPC Biosciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 5th March 2013. After submission, funds are blocked until the basis of allotment of HPC Biosciences IPO is finalised.
The merchant banker for HPC Biosciences IPO is Guiness Corporate Advisors Private Limited . Guiness Corporate Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the HPC Biosciences IPO RHP for further details.
The registrar for HPC Biosciences IPO is Cameo Corporate Services Limited . Investors can go to Cameo Corporate Services Limited registrar website for IPO allotment status, refund processing, and other queries related to HPC Biosciences IPO through their official website or helpline.
HPC Biosciences IPO was subscribed 0.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 15.75 Cr.
Avg IPO Size (Sector Based)
:
₹ 19.40 Cr.
Sector: Agro
SME
IPO so far:
79
Merchant Banker:
Guiness Corporate
SME
IPO by BRLM so far:
47
City:
New Delhi
SME
IPO so far:
165
Revenue (annualised):
₹ 5.46 cr.
PE
Ratio:
8.00x
Average Sector PE Ratio: 18.21x
HPC Biosciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on HPC Biosciences Financial Review Page
Merchant Banker(s) of HPC Biosciences IPO: Guiness Corporate Advisors Private Limited
HPC Biosciences IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
HPC Biosciences IPO listed at a listing price of 39.10 against the offer price of 35.00.
The current market price of HPC Biosciences is 26.20.
Why Us?
